| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006245 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 01/08/2004 | US20040006242 Immunomodulatory compounds and method of use thereof |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006229 Indole derivatives for the treatment of depression and anxiety |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006139 As a food additive, as an animal food additive, as dietary substances, for improving general performances in the fields of sport, strength and endurance areas and, in deficiencies and illnesses of the central and/or peripheral nervous system |
| 01/08/2004 | US20040006135 Combination treatment for depression and anxiety |
| 01/08/2004 | US20040006133 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | US20040006124 Administering compound that is a ryanodine receptor antagonist in pharmaceutically acceptable vehicle to inhibit or prevent nerve cell injury or death |
| 01/08/2004 | US20040006121 Total synthesis of merrilactone A |
| 01/08/2004 | US20040006114 Potentiators of glutamate receptors |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006102 Alkoxy aryl beta2 adrenergic receptor agonists |
| 01/08/2004 | US20040006100 Administering phenylacetic acid derivative for therapy of Parkinson's disease |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event |
| 01/08/2004 | US20040006092 Amidine derivatives for treating amyloidosis |
| 01/08/2004 | US20040006091 Therapeutic agents useful for treating or preventing pain |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/08/2004 | US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006076 Thiazolyl amide derivatives |
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006073 Method of treating attention deficit hyperactivity disorder |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040006044 For therapy and prophylaxis |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040005704 Propagating neuronal cells in reduced oxygen environment for treating parkinson's and neurodegenerative diseases; in vitro culture and cell differentiation/proliferation; gene therapy; tissue engineering; antiapoptosis |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005648 PYK2 related products and methods |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005357 Extended-release tablets comprising divalproex sodium |
| 01/08/2004 | US20040005336 Plurality of yeast cells, wherein said plurality of yeast cells have been cultured in the presence of an alternating electric field having a specific frequency and a specific field strength for a period of time sufficient to increase the |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005307 Modulators of amyloid aggregation |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | DE10227793A1 Stabilisierte Cholinascorbat enthaltende Zusammensetzung Stabilized choline-containing composition |
| 01/08/2004 | DE10227294A1 Zubereitungen zur intranasalen Applikation ausgewählter, von Aminosäuren abgeleiteter CGRP-Antagonisten sowie Verfahren zu deren Herstellung Preparations for nasal administration selected, derived from amino acids CGRP-antagonists as well as methods for their preparation |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | DE10226494A1 Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen Film form mucoadhesive dosage forms for administration of cannabis drugs |
| 01/08/2004 | DE10226459A1 Verwendung von Dopamin-Partialagonisten zur Behandlung des Restless Legs Syndroms Use of dopamine partial agonists for the treatment of Restless Legs Syndrome |
| 01/08/2004 | CA2844639A1 Method for the treatment of multiple sclerosis |
| 01/08/2004 | CA2493854A1 Phosphodiesterase inhibitor |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2492066A1 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | CA2491549A1 Method of promoting smoking cessation |
| 01/08/2004 | CA2491271A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | CA2490804A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | CA2490688A1 Therapeutic agent for brain hemorrhage |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2489688A1 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | CA2487712A1 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | CA2482161A1 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378508A1 Various forms of paroxetine hydrochloride anhydrate |
| 01/07/2004 | EP1378267A1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378238A1 Pharmaceutical compositions containing donepezil hydrochloride |
| 01/07/2004 | EP1378236A1 Agents against stress-induced diseases drugs |
| 01/07/2004 | EP1378235A1 Metoprolol for the treatment of schizophrenia related diseases |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377601A2 Type b botulism toxin inhibitors |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377590A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377581A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377575A1 Antiviral pyrazolopyridine compounds |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377565A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |